OA10195A - Carbazole derivatives with 17 20-lyase-inhibiting activity - Google Patents
Carbazole derivatives with 17 20-lyase-inhibiting activity Download PDFInfo
- Publication number
- OA10195A OA10195A OA60742A OA60742A OA10195A OA 10195 A OA10195 A OA 10195A OA 60742 A OA60742 A OA 60742A OA 60742 A OA60742 A OA 60742A OA 10195 A OA10195 A OA 10195A
- Authority
- OA
- OAPI
- Prior art keywords
- compound
- formula
- group
- daims
- ylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA10195A true OA10195A (en) | 1996-12-18 |
Family
ID=10736007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA60742A OA10195A (en) | 1993-05-21 | 1995-11-17 | Carbazole derivatives with 17 20-lyase-inhibiting activity |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0699196A1 (fr) |
| JP (1) | JPH08510455A (fr) |
| CN (1) | CN1126473A (fr) |
| AU (1) | AU6928794A (fr) |
| BG (1) | BG100154A (fr) |
| CA (1) | CA2162921A1 (fr) |
| CZ (1) | CZ305195A3 (fr) |
| FI (1) | FI955587A0 (fr) |
| GB (1) | GB9310635D0 (fr) |
| HU (1) | HUT73790A (fr) |
| IL (1) | IL109703A0 (fr) |
| NO (1) | NO954681D0 (fr) |
| OA (1) | OA10195A (fr) |
| PE (1) | PE31195A1 (fr) |
| PL (1) | PL311702A1 (fr) |
| SK (1) | SK142495A3 (fr) |
| TW (1) | TW279866B (fr) |
| WO (1) | WO1994027989A1 (fr) |
| ZA (1) | ZA943494B (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT75871A (en) * | 1993-09-30 | 1997-05-28 | Yamanouchi Co | Azole derivatives and pharmaceutical compositions thereof |
| WO1996014090A1 (fr) * | 1994-11-07 | 1996-05-17 | Janssen Pharmaceutica N.V. | Compositions comprenant des carbazoles et des cyclodextrines |
| AU702406B2 (en) * | 1995-03-01 | 1999-02-18 | Yamanouchi Pharmaceutical Co., Ltd. | Imidazole derivatives and medicinal composition thereof |
| ATE231128T1 (de) * | 1997-02-21 | 2003-02-15 | Takeda Chemical Industries Ltd | Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung |
| CN1329394C (zh) | 2000-11-17 | 2007-08-01 | 武田药品工业株式会社 | 新咪唑衍生物、其制备方法及其用途 |
| ATE502030T1 (de) | 2000-11-20 | 2011-04-15 | Takeda Pharmaceutical | Imidazolderivate, verfahren zu deren herstellung und deren verwendung |
| EP1348706B1 (fr) | 2000-12-08 | 2009-08-19 | Takeda Pharmaceutical Company Limited | Derives thiazole substitues porteurs de groupes 3-pyridyl, procede d'elaboration et leur utilisation |
| DE602006012322D1 (de) | 2005-06-24 | 2010-04-01 | Lilly Co Eli | Als androgen-rezeptor-modulatoren verwendbare tetrahydrocarbazol-derivate |
| GB0525323D0 (en) | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
| US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
| CN100586932C (zh) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | 抗肿瘤化合物及其制备方法 |
| ES2475945T3 (es) | 2009-06-26 | 2014-07-11 | Novartis Ag | Derivados imidazolidin-2 -ona 1,3-disustituida como inhibidores de CYP 17 |
| CA2788907A1 (fr) | 2010-02-04 | 2011-08-11 | Radius Health, Inc. | Modulateurs selectifs du recepteur des androgenes |
| CA2799183A1 (fr) | 2010-05-12 | 2011-11-17 | Radius Health, Inc. | Schemas therapeutiques |
| KR101926320B1 (ko) | 2010-08-04 | 2018-12-06 | 펠피큐어 파마슈티걸즈 아이엔씨 | 전립선 암종의 치료를 위한 병용 요법 |
| WO2012035078A1 (fr) | 2010-09-16 | 2012-03-22 | Novartis Ag | Inhibiteurs de la 17α-hydroxylase/c17,20-lyase |
| AU2011312490B2 (en) | 2010-09-28 | 2015-06-25 | Radius Pharmaceuticals, Inc. | Selective androgen receptor modulators |
| CA2834224A1 (fr) | 2011-04-28 | 2012-11-01 | Novartis Ag | Inhibiteurs de 17.alpha.-hydroxylase/c17,20-lyase |
| US9492460B2 (en) * | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
| AU2014241816B9 (en) | 2013-03-14 | 2019-02-14 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
| US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| CA2943611A1 (fr) | 2014-03-28 | 2015-10-01 | Duke University | Methode de traitement du cancer faisant intervenir des modulateurs selectifs des recepteurs des strogenes |
| US10093620B2 (en) | 2014-09-12 | 2018-10-09 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
| KR102397890B1 (ko) | 2016-06-22 | 2022-05-12 | 일립시스 파마 리미티드 | Ar+ 유방암 치료 방법 |
| WO2018080933A1 (fr) | 2016-10-24 | 2018-05-03 | Pellficure Pharmaceuticals Inc. | Compositions pharmaceutiques de 5-hydroxy-2-méthylnaphtalène-1, 4-dione |
| KR102322802B1 (ko) | 2017-01-05 | 2021-11-04 | 래디어스 파마슈티컬스, 인코포레이티드 | Rad1901-2hcl의 다형 형태 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
| GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/xx unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-19 PL PL94311702A patent/PL311702A1/xx unknown
- 1994-05-19 CA CA002162921A patent/CA2162921A1/fr not_active Abandoned
- 1994-05-19 JP JP7500181A patent/JPH08510455A/ja active Pending
- 1994-05-19 SK SK1424-95A patent/SK142495A3/sk unknown
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/cs unknown
- 1994-05-19 HU HU9503321A patent/HUT73790A/hu unknown
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/fr not_active Application Discontinuation
- 1994-05-19 EP EP94917647A patent/EP0699196A1/fr not_active Withdrawn
- 1994-05-19 CN CN94192683A patent/CN1126473A/zh active Pending
- 1994-05-20 IL IL10970394A patent/IL109703A0/xx unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/es not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 FI FI955587A patent/FI955587A0/fi not_active Application Discontinuation
- 1995-11-20 NO NO954681A patent/NO954681D0/no unknown
- 1995-11-21 BG BG100154A patent/BG100154A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA943494B (en) | 1995-01-23 |
| CN1126473A (zh) | 1996-07-10 |
| PE31195A1 (es) | 1995-10-18 |
| FI955587A (fi) | 1995-11-20 |
| HU9503321D0 (en) | 1996-01-29 |
| SK142495A3 (en) | 1996-06-05 |
| AU6928794A (en) | 1994-12-20 |
| EP0699196A1 (fr) | 1996-03-06 |
| HUT73790A (en) | 1996-09-30 |
| FI955587A0 (fi) | 1995-11-20 |
| BG100154A (en) | 1996-07-31 |
| WO1994027989A1 (fr) | 1994-12-08 |
| CA2162921A1 (fr) | 1994-12-08 |
| IL109703A0 (en) | 1994-08-26 |
| CZ305195A3 (en) | 1996-06-12 |
| NO954681L (no) | 1995-11-20 |
| NO954681D0 (no) | 1995-11-20 |
| JPH08510455A (ja) | 1996-11-05 |
| TW279866B (fr) | 1996-07-01 |
| GB9310635D0 (en) | 1993-07-07 |
| PL311702A1 (en) | 1996-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA10195A (en) | Carbazole derivatives with 17 20-lyase-inhibiting activity | |
| EP1373224B1 (fr) | Nouveaux derives spirotricycliques et leur utilisation en tant qu'inhibiteurs de la phosphodiesterase-7 | |
| IE904146A1 (en) | Indole Derivatives | |
| CA2553345C (fr) | Nouvelles formes cristallines d'un inhibiteur de la 11-beta-hydroxysteroide dehydrogenase de type 1 | |
| AU2014300894A1 (en) | Therapeutically active 17-nitrogen substituted estratrienthiazole derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase | |
| SU1549485A3 (ru) | Способ получени производных 6-метиленандроста-1,4-диен-3,17-диона | |
| JP2707936B2 (ja) | β−オキソ−β−ベンゼンプロパンチオアミド誘導体 | |
| Stamm et al. | Reactions with aziridines. 48. Friedel-Crafts reactions with N-sulfonated aziridines and with open-chain sulfonamides. Sulfonamides as leaving groups in open-chain structures | |
| CA2214744C (fr) | Derives de 3-(bis-phenylmethylene substitue) oxindole | |
| KR19980702319A (ko) | 이미다졸 유도체 및 이의 의약 조성물 | |
| US5578630A (en) | Heterocyclic compounds which inhibit aromatase | |
| Branchaud | Studies on the development of the tritylsulfenyl group as a nitrogen protecting group and application in a synthesis of. delta.-coniceine | |
| US6689798B2 (en) | Benzofuran derivatives | |
| EP0240263B1 (fr) | Dérivés d'indénopyrimidines | |
| DK149469B (da) | 3,5-disubstitueret 1h-1,2,4-triazolderivat til anvendelse som antireproduktivt middel | |
| HU229135B1 (en) | Benzofurane derivatives | |
| JP5054882B2 (ja) | テトラヒドロベンズフルオレン誘導体 | |
| KR102406248B1 (ko) | Hsp90 억제제로서의 1,2,3-트리아졸 유도체 화합물 | |
| JPS6258354B2 (fr) | ||
| HU191597B (en) | Process for producing of 2-/2-indalin/-imadazoline preparates and medical preparates consisting of such substances | |
| HUT59107A (en) | Process for producing new 4(5)-imidazole derivatives having aromatase inhibiting activity and pharmaceutical compositions comprising same as active ingredient | |
| US4064177A (en) | 3-Alkoxy-D-homo-C-nor-13α, 14α-gona-1,3,5,(10),6,8-pentaen-17-one and derivatives thereof | |
| JPS6256471A (ja) | 含窒素四環式化合物 | |
| JP2002030063A (ja) | スルファメート化合物の製造方法 | |
| EP0654265A1 (fr) | Composition d'une azole inhibitrice à l'aromatase |